Alume Biosciences, Inc.
Alume Biosciences is a clinical stage biotechnology company developing nerve specific targeting molecules for intraoperative imaging. In addition to ALM-488, Alume is developing other nerve specific agents for diagnostic and therapeutic indications. The company was founded in 2017 and is headquartered in the Johnson & Johnson Innovation incubator JLABS @ San Diego.
Company details
View in map
Find locations served, office locations
- Business Type:
- Technology
- Industry Type:
- Clinical Services
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2017
